BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,378,354 | -22.3% | 36,522 | -6.2% | 0.02% | -21.1% |
| Q2 2023 | $1,774,004 | -30.4% | 38,937 | -38.1% | 0.02% | -34.5% |
| Q1 2023 | $2,550,673 | +47.1% | 62,892 | +84.9% | 0.03% | +45.0% |
| Q4 2022 | $1,733,427 | +2.8% | 34,005 | +8.7% | 0.02% | -9.1% |
| Q3 2022 | $1,686,000 | -17.3% | 31,282 | -1.4% | 0.02% | -15.4% |
| Q2 2022 | $2,038,000 | -16.8% | 31,723 | +0.4% | 0.03% | -3.7% |
| Q1 2022 | $2,450,000 | -8.2% | 31,601 | +1.7% | 0.03% | -3.6% |
| Q4 2021 | $2,668,000 | +6.7% | 31,073 | -0.1% | 0.03% | -3.4% |
| Q3 2021 | $2,501,000 | +5.9% | 31,093 | +6.0% | 0.03% | +3.6% |
| Q2 2021 | $2,361,000 | -3.4% | 29,325 | +1.2% | 0.03% | -9.7% |
| Q1 2021 | $2,444,000 | +59.3% | 28,980 | +51.5% | 0.03% | +34.8% |
| Q4 2020 | $1,534,000 | +1.9% | 19,132 | +2.2% | 0.02% | -11.5% |
| Q3 2020 | $1,506,000 | -8.1% | 18,721 | -1.6% | 0.03% | -16.1% |
| Q2 2020 | $1,638,000 | -31.7% | 19,027 | -35.5% | 0.03% | -34.0% |
| Q1 2020 | $2,397,000 | -5.0% | 29,499 | -2.2% | 0.05% | +14.6% |
| Q4 2019 | $2,523,000 | +11.4% | 30,174 | +16.5% | 0.04% | 0.0% |
| Q3 2019 | $2,265,000 | +8.8% | 25,896 | +1.9% | 0.04% | +5.1% |
| Q2 2019 | $2,082,000 | +3.2% | 25,420 | -2.8% | 0.04% | +11.4% |
| Q1 2019 | $2,018,000 | +20.3% | 26,157 | +2.6% | 0.04% | +6.1% |
| Q4 2018 | $1,678,000 | -23.3% | 25,495 | -10.2% | 0.03% | -15.4% |
| Q3 2018 | $2,189,000 | -2.2% | 28,393 | -6.4% | 0.04% | -11.4% |
| Q2 2018 | $2,239,000 | +16.2% | 30,322 | +2.3% | 0.04% | +10.0% |
| Q1 2018 | $1,927,000 | -5.3% | 29,632 | -5.8% | 0.04% | -7.0% |
| Q4 2017 | $2,034,000 | +6.5% | 31,464 | +3.4% | 0.04% | +16.2% |
| Q3 2017 | $1,909,000 | +4.9% | 30,425 | +1.2% | 0.04% | -9.8% |
| Q2 2017 | $1,819,000 | +16.6% | 30,057 | -0.1% | 0.04% | +7.9% |
| Q1 2017 | $1,560,000 | -67.4% | 30,089 | -72.1% | 0.04% | -64.8% |
| Q4 2016 | $4,778,000 | +81.8% | 107,819 | +95.1% | 0.11% | +66.2% |
| Q3 2016 | $2,628,000 | -11.4% | 55,271 | -15.8% | 0.06% | -25.3% |
| Q2 2016 | $2,967,000 | -36.0% | 65,681 | -41.8% | 0.09% | -39.6% |
| Q1 2016 | $4,635,000 | -3.2% | 112,906 | -10.1% | 0.14% | -7.7% |
| Q4 2015 | $4,790,000 | -5.7% | 125,599 | -18.8% | 0.16% | -12.4% |
| Q3 2015 | $5,081,000 | -54.9% | 154,717 | -4.0% | 0.18% | -51.9% |
| Q2 2015 | $11,264,000 | +22.4% | 161,101 | +19.9% | 0.37% | +22.5% |
| Q1 2015 | $9,204,000 | +19.5% | 134,409 | +27.9% | 0.30% | +19.8% |
| Q4 2014 | $7,699,000 | +16.0% | 105,073 | +13.6% | 0.25% | +12.0% |
| Q3 2014 | $6,636,000 | +4.6% | 92,515 | +5.4% | 0.22% | +4.7% |
| Q2 2014 | $6,343,000 | -4.3% | 87,776 | -2.7% | 0.22% | -9.3% |
| Q1 2014 | $6,631,000 | +8.9% | 90,168 | +2.9% | 0.24% | +4.4% |
| Q4 2013 | $6,089,000 | +24.7% | 87,610 | +17.8% | 0.23% | +3.2% |
| Q3 2013 | $4,882,000 | -5.5% | 74,378 | -0.3% | 0.22% | -11.6% |
| Q2 2013 | $5,165,000 | – | 74,614 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |